Century Therapeutics (IPSC) Invested Capital (2020 - 2026)

Century Therapeutics (IPSC) has 6 years of Invested Capital data on file, last reported at $1.9 million in Q1 2026.

• On a quarterly basis, Invested Capital changed N/A year-over-year to $1.9 million in Q1 2026; TTM through Mar 2026 was $14.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $3.8 million, changed N/A from the prior year.
• Invested Capital for Q1 2026 stood at $1.9 million, down from $3.8 million in the prior quarter.
• Over the last five years, Invested Capital for IPSC reached as high as $10.3 million in Q1 2023 and fell as low as $1.6 million in Q2 2022.
• Historically, Invested Capital has averaged $5.2 million across 4 years, with a median of $4.0 million in 2022.
• On a YoY basis, Invested Capital climbed as much as 525.79% in 2022 and fell as far as 84.06% in 2022.
• Year by year, Invested Capital stood at $6.5 million in 2022, then surged by 58.37% to $10.3 million in 2023, then plunged by 63.51% to $3.8 million in 2025, then slumped by 48.39% to $1.9 million in 2026.
• Per Business Quant data, the three most recent Invested Capital figures were $1.9 million in Q1 2026, $3.8 million in Q4 2025, and $8.3 million in Q3 2025.